August 4, 2022 Experience Gilead Sciences $405 million acquisition of MiroBio We are advising Gilead Sciences on the transaction
August 3, 2022 Experience Taibang Biologic Group $300 million equity raising We are advising Taibang Biologic Group in connection with its equity raising by a group of investors
July 20, 2022 Experience Pon sale of its flow control businesses to MiddleGround Capital We advised Pon on the transaction
June 1, 2022 Experience RedBird Capital Partners acquisition of AC Milan from Elliott Advisors We are advising an affiliate of Elliott Management on the transaction
May 31, 2022 Experience GSK $3.3 billion acquisition of Affinivax We are advising GSK on the acquisition
May 31, 2022 Experience Firmenich €41 billion merger of equals with DSM We are advising Firmenich on the transaction
May 25, 2022 Experience Amdocs $188 million acquisition of MYCOM OSI We are advising Amdocs on the acquisition
May 3, 2022 Experience Atairos $580 million take private of Ocean Outdoor We are advising Atairos on the recommended acquisition